Gene therapy - 291 News

Tip: You can further refine your news selection by departments, organizations, countries and industries.

Gene therapy - 291 News

Tip: You can further refine your news selection by departments, organizations, countries and industries.

image description

CRISPR-Cas technology: ETH researchers have uncovered a serious side effect

A molecule designed to make the process more efficient destroys parts of the genome

05-Dec-2024 - Genome editing with various CRISPR-Cas molecule complexes has progressed rapidly in recent years. Hundreds of labs around the world are now working to put these tools to clinical use and are continuously advancing them. CRISPR-Cas tools allow researchers to modify individual building blocks of ...

gene therapy cancer CRISPR
image description

Merck Reiterates Confidence in Returning to Sustainable Growth

Tailwind thanks to robust global growth trends in all three business sectors

18-Oct-2024 - Merck is looking confidently toward the future. At the Capital Markets Day, the company shared its expectation of profitable and financially strong growth in the coming years. After the transitional year of 2023, Merck considers the medium-term growth opportunities in its markets to be intact. ...

gene therapy antibody-drug conjugates artificial intelligence
image description

Gene therapy against hemophilia

Hannover Medical School (MHH) is one of the first institutions in Germany to be authorized to carry out a new innovative treatment for haemophilia A and B

07-Oct-2024 - Cell and gene therapies are on the rise. This is a new glimmer of hope for people with previously untreatable or barely treatable diseases. Another new therapeutic method has now been added to the list: gene therapy for hemophilia, also known as bleeding disorder. The Hemophilia Center at ...

gene therapy cell therapies coagulation factors
image description

Genespire raises €46.6 million in a Series B round to advance its first pediatric in-vivo gene therapy into the clinic

One of the largest private Italian Biotech company financings to date

01-Oct-2024 - Genespire, a biotechnology company developing off-the-shelf gene therapies for pediatric patients affected by genetic diseases, announced the closing of a €46.6 million (~$52 million) Series B financing, co-led by Sofinnova Partners, XGEN Venture and CDP Venture Capital through its Large Venture ...

gene therapy genetic diseases methylmalonic acidemia
image description

Frontotemporal dementia: therapeutic approach for gene therapy

A new therapeutic approach for the severe condition uses modified viruses to replace a missing protein in the brain

11-Jun-2024 - Frontotemporal dementia is a currently incurable brain disease causing memory loss, speech disorders, and changes in personality. In 5-12% of cases, a decline in progranulin triggers the disease. The loss of this protein leads to deficiencies in protein breakdown, resulting in the deposition of ...

gene therapy brain dementia
image description

Merck Signs Definitive Agreement to Acquire Life Science Company Mirus Bio for US$ 600 million

"This strategic acquisition is a further building block for accelerating growth in the break-through technologies of the future"

24-May-2024 - Merck has signed a definitive agreement to acquire life science company Mirus Bio for US$600million (around €550million). Based in Madison, Wisconsin, USA, Mirus Bio is a specialist in the development and commercialization of transfection reagents. Transfection reagents, such as Mirus Bio's ...

gene therapy cell therapies takeovers
image description

Limula raises CHF 6.2 million to develop automated cell and gene therapy manufacturing platform

Award-winning technology combines a bioreactor and a centrifuge into one single vessel for the first time

23-May-2024 - Over the last decade, several breakthrough Cell and Gene Therapy products have been approved in the USA and Europe to turn stem cells and immune cells into ‘living cures’, bringing hope to millions living with life-threatening conditions. However, these treatments remain out of reach for 98% of ...

gene therapy automation bioreactors
image description

Solvias to Build Biologics and Cell & Gene Therapy Testing Center in Research Triangle Park

Expanding analytical service capabilities for life science companies developing advanced treatments for cancer and rare diseases

08-May-2024 - Solvias announced that it is expanding its global network of laboratory testing centers with a new biotech site in Research Triangle Park, N.C. It is the company's latest investment to expand its analytical testing services supporting life science organizations with the growing number of cell and ...

gene therapy biologics cancer
image description

WACKER Expands Production Capacity for Biopharmaceuticals in San Diego

Wacker Biotech US is expanding its mRNA and protein production

07-May-2024 - As part of its growth strategy for the BIOSOLUTIONS life-science division, WACKER is increasing capacities in the field of biopharmaceuticals for advanced therapies. Wacker Biotech US, a subsidiary specializing in the fermentative production of plasmid DNA (pDNA), is expanding its mRNA and ...

gene therapy biologics biopharmaceutical manufacturing
image description

MIP Discovery closes £7M Series A financing to drive commercialization in cell and gene therapy space

“MIP Discovery’s synthetic affinity reagents hold huge potential to overcome bottlenecks in cell and gene therapy development and production”

28-Feb-2024 - MIP Discovery, an innovative developer of non-biological affinity reagents designed to accelerate the development and production of cell and gene therapies, announced it has closed a £7 million GBP (~$9 million USD) Series A financing round, led by Mercia Ventures. Existing investor Calculus ...

gene therapy cell therapies investments
Search all

These products might interest you

Thermo Scientific TSX Universal Series Ultra-low Temperature Freezer New

Thermo Scientific TSX Universal Series Ultra-low Temperature Freezer by Thermo Fisher Scientific

Over 80 years of innovation packed into the next-generation ultra-low temperature freezer

The pinnacle of reliability, sustainability, and innovation

ultra deep freezers
View product
ZE5 Cell Analyzer

ZE5 Cell Analyzer by Bio-Rad Laboratories

Fast and precise flow cytometry for high-throughput analyses

Reduce labour and increase productivity in drug discovery

flow cytometers
View product
Linkit® AX

Linkit® AX by Sartorius

Precise aliquoting solutions for cell and gene therapy

Uniform liquid distribution and full traceability

filling stations
View product
CellGenix® Growth Factors and Cytokines

CellGenix® Growth Factors and Cytokines by Sartorius

Recombinant growth factors without animal products

Optimised cell culture for T cells and MSCs in gene therapy

reagents
View product
Recombumin® Elite

Recombumin® Elite by Sartorius

ICHQ7 cGMP-compliant albumin for biotechnological applications

Increase consistency and safety for gene therapies and vaccines

reagents
View product
HEK Media

HEK Media by Sartorius

Serum-free cell culture media for HEK cells

Optimised for HEK293 cells and viral vector production, ISO 9001 certified

cell culture media
View product
Ampha X30

Ampha X30 by Amphasys

Ampha X30 Single-Cell Analyzer: for the fast and accurate cell analysis

Efficient cell analysis of viability, count and cell status – without dyes, markers, and incubation

cell analyzers
View product
LPD_GPS_ Centrifugation Project

LPD_GPS_ Centrifugation Project by Thermo Fisher Scientific

Powerful at Every Turn – Meet the NEW General Purpose Centrifuge Family

The most versatile centrifuges designed to fit your application needs

centrifuges
View product
Thermo Scientific™ Heracell™ Vios™ CR CO2 Incubators CTS™ Series

Thermo Scientific™ Heracell™ Vios™ CR CO2 Incubators CTS™ Series by Thermo Fisher Scientific

Next-generation cleanroom confidence for cell therapy research and manufacturing

The first-to-market third party certified cleanroom-compatible CO2 incubator

cell culture incubators
View product
Cell & Gene Therapy Solutions

Cell & Gene Therapy Solutions by Azenta

Transcend Expectations for Cell & Gene Therapy Development with Azenta Life Sciences

Rise above the uncertainty and complexity of cell and gene therapy development

View product
Show all gene therapy

See the theme worlds for related content

Topic world Gene therapy

Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.

View topic world
Topic world Gene therapy

Topic world Gene therapy

Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.

View topic world
Haven't found the right news yet?

The bionity.com news search

Start your targeted search now with a wide range of filter options. Our database includes an archive of 26,753 life science news from business and science, which you can search by topic and organization, filtered by time and geography.

Start news search now